Balancing openness and control: Cross-border health data and AI governance in China

China is increasingly viewing health data as a key strategic asset in its AI ambitions, prompting a complex balancing act between openness and stringent control. This shift is crucial as the nation competes globally in AI, making the governance of cross-border health data a high-stakes issue. The implications extend beyond national borders, influencing international data-sharing norms and raising concerns about data privacy and ethical AI use. This delicate equilibrium could shape the future landscape of global AI development and health information exchange.